Published in Medical Letter on the CDC and FDA, February 5th, 2006
"Each year, cardiovascular disease contributes to nearly half of all deaths in Europe and the European Union, which represents approximately 6 million people," said Paulita LaPlante, president and CEO of Vasamed.
Also cleared for use in the United States by the U.S. Food and Drug Administration (FDA), the AcQtrac System provides accurate, repeatable cardiac and circulatory health information. It utilizes a graphical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.